CDK4/6 Inhibitors in Breast Cancer
CDK4/6 Inhibitors in Breast Cancer
May 29, 2020
medthority.com
Understanding Abemaciclib: A New CDK4/6 Inhibitor | OncLive
Understanding Abemaciclib: A New CDK4/6 Inhibitor | OncLive
Oct 2, 2017
onclive.com
Treatment Selection Post–CDK4/6 Inhibition in Advanced ER+ Breast Cancer | OncLive
Treatment Selection Post–CDK4/6 Inhibition in Advanced ER+ Breas…
1 month ago
onclive.com
CDK4/6 Inhibitor Selection in HR /HER2– Breast Cancer | Oncology Nursing News
1:05
CDK4/6 Inhibitor Selection in HR /HER2– Breast Cancer | Oncology …
5 months ago
oncnursingnews.com
CDK4/6 Inhibitor Therapy in Early-Stage HR /HER2- BC
CDK4/6 Inhibitor Therapy in Early-Stage HR /HER2- BC
1.8K viewsMar 19, 2024
vumedi.com
Dr. O'Regan on Emerging CDK4/6 Combinations in Breast Cancer | OncLive
Dr. O'Regan on Emerging CDK4/6 Combinations in Breast Cancer | …
Aug 14, 2020
onclive.com
Barriers to Adjuvant CDK4/6 Uptake and Evidence for Continued CDK4/6 Use in Metastatic HR Positive Breast Cancer | OncLive
Barriers to Adjuvant CDK4/6 Uptake and Evidence for Continued CDK4…
1 month ago
onclive.com
Serial CDK4/6 Inhibitor Therapy for HR -HER2- MBC: Evolving Insight…
633 viewsAug 13, 2024
vumedi.com
Understanding ESR1 Mutations and the Role of Serial Testing After CD…
3 weeks ago
onclive.com
CDK4/6 Inhibitor Combinations for HR mBC | OncLive
Oct 2, 2017
onclive.com
Dr Escobar on CDK4/6 Inhibitor Selection in HR Metastatic Breast …
11 months ago
onclive.com
Managing CDK4/6 Inhibitor Adverse Events | OncLive
Mar 29, 2019
onclive.com
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Reg…
Sep 30, 2024
reachmd.com
Common Adverse Events With CDK4/6 Inhibitors | Targeted Onco…
Feb 4, 2022
targetedonc.com
Treatment after Progression on CDK4/6 Inhibitors | OncLive
Feb 6, 2023
onclive.com
Dr Conlin on CDK4/6 Inhibitor Sequencing and QOL in Breast Ca…
Aug 11, 2023
onclive.com
Differentiating CDK4/6 Inhibitors in an Evolving European Treatment …
Sep 11, 2024
reachmd.com
Insights from the PATINA Trial: The Role for CDK4/6-Based Maintenan…
1 week ago
onclive.com
Dr Nanda on the Evolution of CDK4/6 Inhibitor Treatment in HR /…
Apr 26, 2024
onclive.com
CDK4/6 Inhibitors for HR Metastatic Breast Cancer | OncLive
Jun 16, 2017
onclive.com
2:02
Post-CDK4/6 Inhibitor Treatment: Guide to HR /HER2- MBC
8 months ago
oncologytube.com
1:54
Cell cycle inhibitors - CDK4/6 inhibitors
16.4K viewsMay 21, 2022
YouTubeScience in Motion
Dr. Harold J. Burstein on CDK4/CDK6 Inhibitor Abemaciclib …
1 week ago
onclive.com
Subgroup Analysis From the Phase 3 EMERALD Trial by Prior Duratio…
3 months ago
managedhealthcareexecutive.com
CDK4/6 inhibitor selection
Apr 21, 2021
medthority.com
0:56
Dr Mayer on PRO Data With Camizestrant Plus CDK4/6 Inhibiti…
4 months ago
onclive.com
Dr Arteaga on CDK4/6 Inhibitor Resistance in ER Breast Cancer | …
Apr 3, 2024
onclive.com
Questioning CDK4/6 Inhibitor Cross-Resistance in HR mBC | OncLive
Jan 15, 2019
onclive.com
When to Choose Chemotherapy vs CDK4/6 Inhibitors | Targeted Onco…
Apr 29, 2019
targetedonc.com
6:16
Mechanisms of Resistance after 1L CDK4/6i ET: The PI3K/AKT/PTEN …
Jul 2, 2024
onclive.com
See more videos
Static thumbnail place holder